0 التعليقات
0 المشاركات
228 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Europe IgA Nephropathy Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032IgA Nephropathy Market According to the latest report published by Data Bridge Market Research, the Europe IgA Nephropathy Market The Europe IgA nephropathy market size was valued at USD 192.49 Million in 2024 and is expected to reach USD 784.54 Million by 2032, at a CAGR of 19.2% during the forecast period The market growth is largely fueled by the...0 التعليقات 0 المشاركات 281 مشاهدة 0 معاينة
-
IgA Nephropathy Treatment MarketAccording to the latest report published by Data Bridge Market Research, the Immunoglobulin A (IgA) Nephropathy Market CAGR Value The global Immunoglobulin A (IgA) Nephropathy market size was valued at USD 178.25 Million in 2025and is expected to reach USD 771.56 Million by 2033, at a CAGR of 20.10% during the forecast period A comprehensive...0 التعليقات 0 المشاركات 323 مشاهدة 0 معاينة
-
IgA Nephropathy Treatment Market – Immunosuppressive Therapy Remains the Largest SegmentImmunosuppressive therapy remains the largest treatment segment in the IgA nephropathy treatment market, accounting for roughly 52.4% of market share. Its leadership reflects the role of immune-related mechanisms in the disease and the need for therapeutic approaches that address inflammation and potential kidney damage.marketresearchfuture Treatment selection depends on disease severity,...0 التعليقات 0 المشاركات 229 مشاهدة 0 معاينة
-
Innovation Trends Shaping the Southeast Asia IgA Nephropathy MarketIndonesia, Malaysia, Philippines, Thailand and Vietnam IgA Nephropathy Market According to the latest report published by Data Bridge Market Research, the Indonesia, Malaysia, Philippines, Thailand and Vietnam IgA Nephropathy Market Data Bridge Market Research analyzes that the Indonesia, Malaysia, Thailand, Philippines, and Vietnam IgA nephropathy market is expected to reach USD...0 التعليقات 0 المشاركات 289 مشاهدة 0 معاينة
-
Ionis (IONS) partner Roche shows sefaxersen cut IgA nephropathy proteinuria 43.1% in Phase 3Roche gave the first effect size from its IMAgINATION kidney trial at ASN Kidney Week, a clearer read for Ionis Pharmaceuticals Inc. (IONS) on a partnered drug that carries milestones and royalties. Sefaxersen cut proteinuria by 43.1% against placebo at 37 weeks in a Phase 3 trial in IgA nephropathy, according to data Ionis Pharmaceuticals Inc. (IONS) released on October 23. Roche Holding AG,...0 التعليقات 0 المشاركات 8 مشاهدة 0 معاينة
-
Key Developments Across Iga Nephropathy Drugs MarketThe Iga Nephropathy Drugs Market continues to expand as the demand for targeted therapeutic interventions for the most common primary glomerulonephritis intensifies across nephrology clinics, academic medical centers, and pharmaceutical development pipelines worldwide. IgA nephropathy drugs encompass a growing portfolio of immunomodulatory, anti-inflammatory, and complement-targeting agents...0 التعليقات 0 المشاركات 311 مشاهدة 0 معاينة
-
Middle East & Africa IgA Nephropathy Market Trends: The Growth Opportunities Your Competitors Are Already ExploringMiddle East and Africa IgA Nephropathy Market According to the latest report published by Data Bridge Market Research, the Middle East and Africa IgA Nephropathy Market The Middle East and Africa IgA nephropathy market size was valued at USD 16.52 Million in 2024 and is expected to reach USD 64.66 Million by 2032, at a CAGR of 18.60% during the forecast...0 التعليقات 0 المشاركات 374 مشاهدة 0 معاينة
-
The Silent Kidney Disease: Understanding the IgA Nephropathy Treatment MarketThe IgA Nephropathy Treatment Market is a vital and rapidly evolving segment of the global nephrology landscape, addressing a chronic, autoimmune kidney disease that can lead to end-stage renal failure. IgA nephropathy (IgAN) occurs when the antibody immunoglobulin A (IgA) deposits in the kidneys, causing inflammation and progressive damage. Currently valued at approximately USD 2.05...0 التعليقات 0 المشاركات 248 مشاهدة 0 معاينة
-
The Treatment Landscape: Types, Severity, and Patient Populations in IgA NephropathyThe IgA nephropathy treatment market encompasses a diverse range of treatment types, disease severity segments, and patient populations that are critical to managing this complex kidney condition. From immunosuppressive therapy and plasmapheresis to dialysis and kidney transplant, each treatment modality addresses specific stages and manifestations of the disease. Understanding these segments...0 التعليقات 0 المشاركات 239 مشاهدة 0 معاينة
-
Immunoglobulin A Nephropathy Market: Therapeutic Innovations, Growth Opportunities & Industry AnalysisAccording to the latest report published by Data Bridge Market Research, the Immunoglobulin A (IgA) Nephropathy Market CAGR Value As per Data Bridge Market Research Analysis the global Immunoglobulin A (IgA) Nephropathy market size was valued at USD 178.25 Million in 2025and is expected to reach USD 771.56 Million by 2033, at a CAGR of 20.10% during the forecast period...0 التعليقات 0 المشاركات 45 مشاهدة 0 معاينة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek